Christopher W Krueger is CHIEF BUSINESS OFFICER of Ventyx Biosciences, Inc.. Currently has a direct ownership of 284,999 shares of VTYX, which is worth approximately $638,397. The most recent transaction as insider was on Apr 02, 2024, when has been sold 1,651 shares (Common Stock) at a price of $5.4 per share, resulting in proceeds of $8,915. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 285K
0% 3M change
1.02% 12M change
Total Value Held $638,397

Christopher W Krueger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
SELL
Open market or private sale
$8,915 $5.4 p/Share
1,651 Reduced 0.58%
284,999 Common Stock
Mar 28 2024
BUY
Exercise of conversion of derivative security
-
4,531 Added 1.56%
286,650 Common Stock
Dec 20 2023
SELL
Open market or private sale
$11,221 $2.12 p/Share
5,293 Reduced 1.84%
282,119 Common Stock
Dec 17 2023
BUY
Exercise of conversion of derivative security
-
10,479 Added 3.52%
287,412 Common Stock
Oct 03 2023
SELL
Open market or private sale
$454,800 $30.32 p/Share
15,000 Reduced 5.14%
276,548 Common Stock
Oct 03 2023
BUY
Exercise of conversion of derivative security
$120,599 $8.04 p/Share
15,000 Added 4.89%
291,548 Common Stock
Sep 05 2023
SELL
Open market or private sale
$498,150 $33.21 p/Share
15,000 Reduced 5.14%
276,548 Common Stock
Sep 05 2023
BUY
Exercise of conversion of derivative security
$120,599 $8.04 p/Share
15,000 Added 4.89%
291,548 Common Stock
Aug 03 2023
SELL
Open market or private sale
$535,950 $35.73 p/Share
15,000 Reduced 5.14%
276,548 Common Stock
Aug 03 2023
BUY
Exercise of conversion of derivative security
$120,599 $8.04 p/Share
15,000 Added 4.89%
291,548 Common Stock
Jul 03 2023
SELL
Open market or private sale
$551,250 $36.75 p/Share
15,000 Reduced 5.14%
276,548 Common Stock
Jul 03 2023
BUY
Exercise of conversion of derivative security
$61,800 $4.12 p/Share
15,000 Added 4.89%
291,548 Common Stock
Jun 05 2023
SELL
Open market or private sale
$517,199 $34.48 p/Share
15,000 Reduced 5.14%
276,548 Common Stock
Jun 05 2023
BUY
Exercise of conversion of derivative security
$61,800 $4.12 p/Share
15,000 Added 4.89%
291,548 Common Stock
May 03 2023
SELL
Open market or private sale
$578,400 $38.56 p/Share
15,000 Reduced 5.15%
276,117 Common Stock
May 03 2023
BUY
Exercise of conversion of derivative security
$120,599 $8.04 p/Share
15,000 Added 4.9%
291,117 Common Stock
Dec 22 2022
SELL
Open market or private sale
$115,502 $31.61 p/Share
3,654 Reduced 1.28%
282,670 Common Stock
Dec 17 2022
BUY
Exercise of conversion of derivative security
-
10,480 Added 3.53%
286,324 Common Stock
Dec 13 2022
SELL
Open market or private sale
$1,033,800 $34.46 p/Share
30,000 Reduced 9.91%
272,692 Common Stock
Dec 02 2022
SELL
Open market or private sale
$1,450,500 $29.01 p/Share
50,000 Reduced 14.18%
302,692 Common Stock
Aug 23 2022
BUY
Exercise of conversion of derivative security
$33,872 $0.2 p/Share
169,361 Added 32.44%
352,692 Common Stock
Apr 03 2022
SELL
Open market or private sale
$493,200 $32.88 p/Share
15,000 Reduced 5.15%
276,117 Common Stock
Apr 03 2022
BUY
Exercise of conversion of derivative security
$48,908 $5.79 p/Share
8,447 Added 2.82%
291,117 Common Stock
CWK

Christopher W Krueger

CHIEF BUSINESS OFFICER
Encinitas, CA

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX